Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Brooks

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Physiological Genomics|November 14, 2000
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartanV Y Wong, N J Laping, L C Contino, et al.
European Journal of Pharmacology|February 26, 1991
Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor numberD P Brooks, E H Ohlstein, L C Contino, et al.
European Journal of Pharmacology|August 2, 1990
Effect of fenoldopam in dogs with spontaneous renal insufficiencyD P Brooks, R Goldstein, P F Koster, et al.
Molecular Pharmacology|October 10, 1997
Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligandsP Nambi, M Pullen, J Kincaid, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependentD P Brooks, R M Edwards, P D Depalma, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablationD P Brooks, L C Contino, W Trizna, et al.
The American Journal of Physiology|March 1, 1985
High potassium intake selectively increases urinary PGF2 alpha excretion in the ratA Nasjletti, A Erman, L M Cagen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Increased urinary vasopressin excretion in the DOCA-hypertensive pigD P Brooks, J T Crofton, L Share, et al.
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogsC R Albrightson-Winslow, N Caldwell, D P Brooks, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Physiological Genomics|November 14, 2000
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartanV Y Wong, N J Laping, L C Contino, et al.
European Journal of Pharmacology|February 26, 1991
Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor numberD P Brooks, E H Ohlstein, L C Contino, et al.
European Journal of Pharmacology|August 2, 1990
Effect of fenoldopam in dogs with spontaneous renal insufficiencyD P Brooks, R Goldstein, P F Koster, et al.
Molecular Pharmacology|October 10, 1997
Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligandsP Nambi, M Pullen, J Kincaid, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependentD P Brooks, R M Edwards, P D Depalma, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablationD P Brooks, L C Contino, W Trizna, et al.
The American Journal of Physiology|March 1, 1985
High potassium intake selectively increases urinary PGF2 alpha excretion in the ratA Nasjletti, A Erman, L M Cagen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Increased urinary vasopressin excretion in the DOCA-hypertensive pigD P Brooks, J T Crofton, L Share, et al.
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogsC R Albrightson-Winslow, N Caldwell, D P Brooks, et al.
Pageof 15